We expect to focus on identifying potential target companies with above-industry-average growth, substantial free cash flow generation, and a defensible market position with an enterprise value of $500 million to $1.5 billion where our management team’s operational, strategic or managerial expertise can assist in maximizing value. Our sponsor is Live Oak Sponsor Partners II, LLC, a Delaware limited liability […]

Mark Ein and Dyson Dryden have established Capitol Investment Corp. V, their fifth blank check company, to invest in and help build an industry-leading public company that will aim to deliver long-term value to stockholders. We are one of only two U.S. sponsor teams of SPACs over $100 million in size to close four SPAC transactions.  Mr. […]

(Note: This is not an IPO. This is a step-up, or an uplift, to the NASDAQ from the OTCQB. IPOScoop has a “No Call” rating on this deal because it is a step-up or uplift deal, also known as an up-listing. Total revenue and net income figures are consolidated GAAP figures for the last 12 […]

We are one of the largest and most recognized players in the Peruvian healthcare industry and have a growing presence in Colombia. With more than 30 years of experience in the healthcare industry, we provide oncology healthcare plans in Peru and operate hospitals and clinics in Peru and Colombia that provide high-quality medical services at […]

We are a technology-driven business that is an innovator in the lottery industry. As a global B2G and B2B technology and service provider to state lotteries and other lottery operators, we offer our customers a full-service solution that includes all of the elements required for the offering of lottery games, including Instants and DBGs, via […]

We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of next-generation targeted therapies for women’s cancers. Our team has spent the past decade characterizing the structure and function of the estrogen receptor, or ER, a key driver of breast cancer in approximately 75% of patients, in order to develop more potent, […]

We intend to capitalize on the ability of our management team and sponsor to identity, acquire and manage a business in the financial services and financial technology sectors, including payments, enterprise software, and data analytics, that can benefit from our differentiated deal flow and global network. Our sponsor, Concord Sponsor Group LLC, is affiliated with […]

We intend to focus our search on businesses in the technology industry with their primary operations in Asia and an enterprise value between $100 million and $200 million. We believe that we will add value to these businesses primarily by providing them with access to the U.S. capital markets. We will seek to capitalize on […]

(Note: Ozon is sometimes called “Russia’s Amazon.” Total revenue and net loss figures in this profile are for the last 12 months, with reporting period ended Sept. 30, 2020, translated into U.S. dollars from billions of Russian roubles, as presented in the prospectus.) We believe that we are one of the pioneers of e-commerce and the most […]

We intend to seek to acquire companies with an enterprise value in the range of $1.0 billion to $5.0 billion and with a focus on the consumer, healthcare, industrial and technology sectors. This new blank-check company is affiliated with Investindustrial, which was founded in 1990 as an independent investment group with financial backing from the Bonomi […]